Vascular factors in diabetic neuropathy

S. Tesfaye, Rayaz Malik, J. D. Ward

Research output: Contribution to journalReview article

201 Citations (Scopus)

Abstract

Despite considerable research we still do not have a comprehensive explanation for the pathogenesis of diabetic neuropathy. Although chronic hyperglycaemia is almost certainly involved, it is not known whether the primary pathology is metabolic, microvascular, or an interaction between the two. Hyperglycaemia-induced polyol pathway hyperactivity associated with nerve sorbitol accumulation and myo-inositol depletion may play a part in the genesis of diabetic neuropathy. The case for microvascular disease in diabetic neuropathy is now strong. Fibre loss in human sural nerve is multifocal, suggesting ischaemia. The degree of vessel disease has been related to the severity of neuropathy. People with chronic obstructive pulmonary disease develop the so called "hypoxic neuropathy" in which similar microvascular changes occur as in diabetic neuropathy. In rats with experimental diabetic neuropathy nerve blood flow is reduced and oxygen supplementation or vasodilator treatment improved the deterioration in conduction velocity and nerve blood flow. Similarly, in human diabetic neuropathy, there is impaired nerve blood flow, epineurial arterio-venous shunting and a reduction in sural nerve oxygen tension. At what stage during the development of nerve damage these changes occur is yet to be determined.

Original languageEnglish
Pages (from-to)847-854
Number of pages8
JournalDiabetologia
Volume37
Issue number9
DOIs
Publication statusPublished - Sep 1994
Externally publishedYes

Fingerprint

Diabetic Neuropathies
Sural Nerve
Hyperglycemia
Oxygen
Sorbitol
Blood Flow Velocity
Neural Conduction
Inositol
Vasodilator Agents
Chronic Obstructive Pulmonary Disease
vascular factor
Ischemia
Pathology
Research

Keywords

  • blood flow
  • Diabetic neuropathy
  • hypoxia
  • microangiopathy
  • nerve

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Vascular factors in diabetic neuropathy. / Tesfaye, S.; Malik, Rayaz; Ward, J. D.

In: Diabetologia, Vol. 37, No. 9, 09.1994, p. 847-854.

Research output: Contribution to journalReview article

Tesfaye, S. ; Malik, Rayaz ; Ward, J. D. / Vascular factors in diabetic neuropathy. In: Diabetologia. 1994 ; Vol. 37, No. 9. pp. 847-854.
@article{6be68be6699c4411a193ebef7146a784,
title = "Vascular factors in diabetic neuropathy",
abstract = "Despite considerable research we still do not have a comprehensive explanation for the pathogenesis of diabetic neuropathy. Although chronic hyperglycaemia is almost certainly involved, it is not known whether the primary pathology is metabolic, microvascular, or an interaction between the two. Hyperglycaemia-induced polyol pathway hyperactivity associated with nerve sorbitol accumulation and myo-inositol depletion may play a part in the genesis of diabetic neuropathy. The case for microvascular disease in diabetic neuropathy is now strong. Fibre loss in human sural nerve is multifocal, suggesting ischaemia. The degree of vessel disease has been related to the severity of neuropathy. People with chronic obstructive pulmonary disease develop the so called {"}hypoxic neuropathy{"} in which similar microvascular changes occur as in diabetic neuropathy. In rats with experimental diabetic neuropathy nerve blood flow is reduced and oxygen supplementation or vasodilator treatment improved the deterioration in conduction velocity and nerve blood flow. Similarly, in human diabetic neuropathy, there is impaired nerve blood flow, epineurial arterio-venous shunting and a reduction in sural nerve oxygen tension. At what stage during the development of nerve damage these changes occur is yet to be determined.",
keywords = "blood flow, Diabetic neuropathy, hypoxia, microangiopathy, nerve",
author = "S. Tesfaye and Rayaz Malik and Ward, {J. D.}",
year = "1994",
month = "9",
doi = "10.1007/BF00400938",
language = "English",
volume = "37",
pages = "847--854",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "9",

}

TY - JOUR

T1 - Vascular factors in diabetic neuropathy

AU - Tesfaye, S.

AU - Malik, Rayaz

AU - Ward, J. D.

PY - 1994/9

Y1 - 1994/9

N2 - Despite considerable research we still do not have a comprehensive explanation for the pathogenesis of diabetic neuropathy. Although chronic hyperglycaemia is almost certainly involved, it is not known whether the primary pathology is metabolic, microvascular, or an interaction between the two. Hyperglycaemia-induced polyol pathway hyperactivity associated with nerve sorbitol accumulation and myo-inositol depletion may play a part in the genesis of diabetic neuropathy. The case for microvascular disease in diabetic neuropathy is now strong. Fibre loss in human sural nerve is multifocal, suggesting ischaemia. The degree of vessel disease has been related to the severity of neuropathy. People with chronic obstructive pulmonary disease develop the so called "hypoxic neuropathy" in which similar microvascular changes occur as in diabetic neuropathy. In rats with experimental diabetic neuropathy nerve blood flow is reduced and oxygen supplementation or vasodilator treatment improved the deterioration in conduction velocity and nerve blood flow. Similarly, in human diabetic neuropathy, there is impaired nerve blood flow, epineurial arterio-venous shunting and a reduction in sural nerve oxygen tension. At what stage during the development of nerve damage these changes occur is yet to be determined.

AB - Despite considerable research we still do not have a comprehensive explanation for the pathogenesis of diabetic neuropathy. Although chronic hyperglycaemia is almost certainly involved, it is not known whether the primary pathology is metabolic, microvascular, or an interaction between the two. Hyperglycaemia-induced polyol pathway hyperactivity associated with nerve sorbitol accumulation and myo-inositol depletion may play a part in the genesis of diabetic neuropathy. The case for microvascular disease in diabetic neuropathy is now strong. Fibre loss in human sural nerve is multifocal, suggesting ischaemia. The degree of vessel disease has been related to the severity of neuropathy. People with chronic obstructive pulmonary disease develop the so called "hypoxic neuropathy" in which similar microvascular changes occur as in diabetic neuropathy. In rats with experimental diabetic neuropathy nerve blood flow is reduced and oxygen supplementation or vasodilator treatment improved the deterioration in conduction velocity and nerve blood flow. Similarly, in human diabetic neuropathy, there is impaired nerve blood flow, epineurial arterio-venous shunting and a reduction in sural nerve oxygen tension. At what stage during the development of nerve damage these changes occur is yet to be determined.

KW - blood flow

KW - Diabetic neuropathy

KW - hypoxia

KW - microangiopathy

KW - nerve

UR - http://www.scopus.com/inward/record.url?scp=0028095119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028095119&partnerID=8YFLogxK

U2 - 10.1007/BF00400938

DO - 10.1007/BF00400938

M3 - Review article

VL - 37

SP - 847

EP - 854

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 9

ER -